|
Remote Digital Care Effects in Adolescents With Type 1 Diabetes
RECRUITINGN/ASponsored by University Hospital, Toulouse
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital, Toulouse
Started2023-04-11
Est. completion2024-12-01
Eligibility
Age12 Years – 17 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05421715
Summary
Pilot study to evaluate effects of an experimental additional remote digital care (TELEDUC-DIAB) to adolescents with poorly controlled type 1 diabetes using digital monitoring platform and educative app
Eligibility
Age: 12 Years – 17 YearsHealthy volunteers accepted
Inclusion Criteria: * Adolescent aged ≥12 and \<18, with primary type 1 diabetes detected for at least 12 months, treated with multi-injection insulin or insulin pump * Glycated hemoglobin greater than or equal to 8% for more than 3 months * Use a continuous interstitial glucose recording system (CGM) * Have at least one parent/guardian with a significant caregiver role in the management of the adolescent's diabetes (as determined by the investigator) participating in the study * Have digital media compatible with the digital applications of the TELEDUC- DIAB (Mobile phone and computer) Exclusion Criteria: • Other pathologies associated with diabetes which, according to the investigator, could interfere with glycemic control or the management of adolescent diabetes (examples: secondary diabetes, cystic fibrosis, Down syndrome; transplants, corticosteroid therapy, etc.)
Conditions2
DiabetesType1diabetes
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital, Toulouse
Started2023-04-11
Est. completion2024-12-01
Eligibility
Age12 Years – 17 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05421715